title: Application of natural killer T-cells to posttransplantation immunotherapy.
abstract: Graft-versus-host disease (GVHD) and graft-versus leukemia (GVL) effects are closely related to each other after allogeneic stem cell transplantation. This association exists because of the extensive and complicated interaction between cellular donor components and recipient components concomitant with cytokine storms. It has been demonstrated that part of this interaction may be related to the induction of a variety of regulatory cells, such as regulatory T-cells and natural killer T (NKT) cells. A lower number of NKT cells may be found in patients with autoimmune diseases, cancer, viral infection, and severe GVHD. When activated, NKT cells rapidly release suppressive cytokines, such as interleukin 4 (IL-4), IL-10, and IL-13, as well as inflammatory cytokines, such as interferon gamma and tumor necrosis factor alpha. NKT cells therefore act as a double-edged sword in their progressive or suppressive effects on diseases. Such contradictory phenomena may be related to the function or types of antigen-presenting cells (APCs) in response to their ligand. A single-dose injection of a ligand for NKT cells, alpha-galactosylceramide (alpha-GalCer), can induce immunity through fully mature dendritic cells in an antigen-specific manner. By contrast, multiple injections of alpha-GalCer would induce tolerance, which may be caused by immature APCs. This response suggests that the function of NKT cells can be determined by alpha-GalCer for controlling the immune response. Furthermore, activation of NKT cells followed by activation of APCs and IL-12 production may lead to activation of NK cells and suppress GVHD in mismatched major histocompatibility complex combinations or may induce GVL effects. Control and modification of NKT cell function may play an important role in regulating GVHD/GVL effects.
authors.affiliation: Research Unit for Cellular Immunotherapy, Research Center for Allergy and Immunology, Riken, Yokohama, Kanagawa, Japan. fujiis@rcai.riken.jp
authors.forename: Shin-ichiro
authors.initials: S
authors.lastname: Fujii
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation / Q000276:immunology*; D006086:Graft vs Host Disease / Q000276:immunology*; D020544:Graft vs Leukemia Effect / Q000276:immunology*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*
references.citation: Br J Haematol. 2003 Aug;122(4):617-22
references.pmid: 12899717
references.citation: Curr Opin Immunol. 2004 Apr;16(2):157-62
references.pmid: 15023407
references.citation: Blood. 2002 Feb 15;99(4):1259-66
references.pmid: 11830474
references.citation: Blood. 2000 May 1;95(9):2754-9
references.pmid: 10779417
references.citation: J Exp Med. 2003 Dec 1;198(11):1741-52
references.pmid: 14657224
references.citation: J Exp Med. 1999 Apr 5;189(7):1121-8
references.pmid: 10190903
references.citation: Exp Hematol. 2004 Jul;32(7):630-7
references.pmid: 15246159
references.citation: J Exp Med. 2003 Jul 21;198(2):267-79
references.pmid: 12874260
references.citation: J Exp Med. 2000 Sep 4;192(5):755-60
references.pmid: 10974040
references.citation: J Exp Med. 1999 Apr 5;189(7):1073-81
references.pmid: 10190898
references.citation: J Clin Invest. 2000 Jun;105(12):1761-7
references.pmid: 10862791
references.citation: J Immunol. 1996 May 15;156(10):4035-40
references.pmid: 8621946
references.citation: Nature. 2001 Oct 4;413(6855):531-4
references.pmid: 11586362
references.citation: J Immunol. 1999 Nov 15;163(10):5338-45
references.pmid: 10553057
references.citation: J Exp Med. 2003 Jun 16;197(12):1667-76
references.pmid: 12796469
references.citation: Br J Haematol. 2004 May;125(3):400-4
references.pmid: 15086423
references.citation: Blood. 2004 Feb 1;103(3):767-76
references.pmid: 12958064
references.citation: J Exp Med. 1998 Jun 15;187(12):2109-14
references.pmid: 9625772
references.citation: Int J Hematol. 2003 Jul;78(1):7-17
references.pmid: 12894845
references.citation: J Exp Med. 2002 Aug 5;196(3):389-99
references.pmid: 12163567
references.citation: Curr Opin Immunol. 2003 Dec;15(6):683-9
references.pmid: 14630203
references.citation: J Immunol. 2003 Nov 15;171(10):5140-7
references.pmid: 14607913
references.citation: J Exp Med. 2003 Apr 7;197(7):919-25
references.pmid: 12682111
references.citation: J Exp Med. 1987 Nov 1;166(5):1280-9
references.pmid: 3316469
references.citation: J Immunol. 1992 Jan 15;148(2):373-80
references.pmid: 1309556
references.citation: Science. 2002 Mar 15;295(5562):2097-100
references.pmid: 11896281
references.citation: J Immunol. 2001 Mar 15;166(6):4209-15
references.pmid: 11238673
references.citation: Int J Hematol. 2001 Jul;74(1):26-32
references.pmid: 11530801
references.citation: Eur J Immunol. 2002 Sep;32(9):2551-61
references.pmid: 12207339
references.citation: Nat Immunol. 2002 Sep;3(9):867-74
references.pmid: 12154358
references.citation: J Exp Med. 1998 Apr 6;187(7):1047-56
references.pmid: 9529321
references.citation: J Immunol. 2002 Nov 15;169(10):5564-70
references.pmid: 12421933
references.citation: Nat Med. 1997 Apr;3(4):409-13
references.pmid: 9095174
references.citation: J Immunol. 2004 Feb 1;172(3):1333-9
references.pmid: 14734707
references.citation: Curr Opin Hematol. 2001 Nov;8(6):355-9
references.pmid: 11604575
references.citation: J Exp Med. 2004 Jun 21;199(12):1607-18
references.pmid: 15197224
references.citation: Nat Rev Immunol. 2002 Dec;2(12):957-64
references.pmid: 12461568
references.citation: Eur J Immunol. 2000 Apr;30(4):985-92
references.pmid: 10760785
references.citation: J Immunol Methods. 2003 Jan 15;272(1-2):147-59
references.pmid: 12505720
references.citation: Bone Marrow Transplant. 2004 Oct;34(7):595-602
references.pmid: 15300228
references.citation: Nat Med. 2001 Sep;7(9):1052-6
references.pmid: 11533710
references.citation: Blood. 2002 Sep 1;100(5):1728-33
references.pmid: 12176894
references.citation: J Immunol. 1990 Nov 15;145(10):3209-15
references.pmid: 1977798
references.citation: Nat Immunol. 2002 Jan;3(1):6-8
references.pmid: 11753399
references.citation: Blood. 1998 Jun 1;91(11):4051-5
references.pmid: 9596649
references.citation: Nat Med. 2002 Jun;8(6):575-81
references.pmid: 12042807
references.citation: J Immunol. 1985 Nov;135(5):3004-10
references.pmid: 3876371
references.citation: Nat Immunol. 2000 Dec;1(6):515-20
references.pmid: 11101874
references.citation: J Immunol. 2001 Aug 15;167(4):2087-96
references.pmid: 11489992
references.citation: Blood. 2001 May 15;97(10):2923-31
references.pmid: 11342413